Mobile Marketing
What Would A Pharma Marketing Champ Do? 9 Imperatives for 2010
Friday, February 5th, 2010
This is the final post of a four-part series. Steve Jobs, Google, Good Life are three marketing champs. Read what Pharma marketing champs would do.
Read the full story
The New Year’s Epiphany
Thursday, January 21st, 2010
It’s not often that I am behind the tech curve, and even worse, my PARENTS were on board before me.
Read the full story
It’s Just Not About YOU
Tuesday, December 22nd, 2009
I’ve been a leader for a long time and I’ve been a manager for a long time. I think I am a strong leader; I think I am an OK manager – there is always room for improvement in all arenas, of course. Somehow I have assumed that by being a strong leader that I am by rote being a good manager.
Read the full story
How To Be One of One Hundred
Tuesday, December 15th, 2009
There were at least 100 people in Starbucks at 53rd and Broadway at 1:45 p.m.
Read the full story
The Willingness to Try
Thursday, December 3rd, 2009
One of my strengths that plays well as leader of One Eleven is my willingness to try something. Anything, really.
Read the full story
Defining the Optimal User Experience for Mobile
Tuesday, October 6th, 2009
I recently had the pleasure of acquiring a MINI Cooper Clubman. The car is zippy and fun.
Read the full story
IBM targets faster, cheaper sequencing
Tuesday, October 6th, 2009
IBM is joining the genomic revolution. And the computing giant is already talking about taking the race to cut the cost of sequencing a genome–now focused on the $1,000 mark–to a whole new level as it leapfrogs into a leading position.
Read the full story
FDA panel backs Glaxo’s new kidney cancer drug
Tuesday, October 6th, 2009
An expert panel gathered by the FDA has endorsed GlaxoSmithKline’s new kidney cancer therapy,
Read the full story
SurModics shares surge on $200M Roche pact
Tuesday, October 6th, 2009
Shares of SurModics surged 21 percent this morning after the drug delivery company announced it had scored a $200 million licensing deal with Roche and Genentech. Genentech will use SurModics’ microparticle delivery technology to develop a sustained drug delivery formulation of Lucentis as well as other opthalmology drugs.
Read the full story
GSK’s top dealmaker joins FierceBiotech panel
Monday, October 5th, 2009
I’m very pleased to report that we’ve enlisted the help of Ad Rawcliffe for our upcoming webinar on landing a deal , which is
Read the full story
Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice